Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

(2012) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Potential negative effects of epinephrine on carotid blood flow and ETCO2 during active compression–decompression CPR utilizing an impedance threshold device

(2012) Aaron M. Burnett et al.   RESUSCITATION

Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis

(2012) M. Giglio et al.   Interactive Cardiovascular and Thoracic Surgery

Variation in use of peroperative inotropic support therapy in cardiac surgery: time for reflection?

(2011) D. V. NIELSEN et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery

(2011) H Leppikangas et al.   BRITISH JOURNAL OF ANAESTHESIA

Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial*

(2011) Pasi Lahtinen et al.   CRITICAL CARE MEDICINE

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*

(2011) Giovanni Landoni et al.   CRITICAL CARE MEDICINE

Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide☆☆☆

(2011) Philippe Primo Caimmi et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes

(2011) Thomais Markou et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial KATP channel and potential pERK 1/2 activation

(2011) Paul F. Soeding et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Levosimendan Facilitates Weaning From Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting With Impaired Left Ventricular Function

(2009) Heidi I. Eriksson et al.   ANNALS OF THORACIC SURGERY

Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery †

(2009) L. Tritapepe et al.   BRITISH JOURNAL OF ANAESTHESIA

Reducing Mortality in Cardiac Surgery With Levosimendan: A Meta-analysis of Randomized Controlled Trials

(2009) Giovanni Landoni et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB)

(2009) Imdad Ahmed et al.   Journal of Cardiothoracic Surgery

Troponin after Cardiac Surgery: A Predictor or a Phenomenon?

(2008) Nahum Nesher et al.   ANNALS OF THORACIC SURGERY

Levosimendan in Aortic Valve Surgery: Cardiac Performance and Recovery

(2008) Kati Järvelä et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Superioridad del sensibilizante al calcio levosimendán comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorio

(2008) Ricardo L. Levin et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs

(2007) Patricia N. Banfor et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY